~ stronger variant – PiFLU-800 & Favenza-800 – helps reduce dosage frequency as well as cost ~ Home-grown pharma major, FDC Limited, today announced the launch of new strength variants of its Favipiravir brands – PiFLU and Favenza, used to treat mild to moderate cases of COVID-19 in India. These prescription-only drugs